ROCKET STOCK…. RPG LIFE SCINCES Ltd. At 21.35/-; TARGET 35/-
Published on Sunday, December 21st, 2008 at 9:07 AMAuthor: india_bulls (143 Articles)
ROCKET STOCK…. RPG LIFE SCINCES Ltd. At 21.35/-; TARGET 35/-
RPG LIFE SCINCES Ltd Trading in BSE & NSE at 21.35/- . Target 35/- for short term.
Market is stabilizing between 9,500 to 11,000. Coming week NIFTY will touch 3,250/- and Sensex will touch 10,785. This week (22nd Dec to 26th Dec) Mid cap and small cap rally will expecting.
Right time to Enter Good Fundamental Stocks for short term. If you enter good Fundamental Stocks at present rate you will get 50% appreciation within short time.
RPG LIFE SCINCES Ltd; is R P Goenka Group Company, Dividend Paying Company (15% for 2007-08; Book Closure Date 13 August 2008 to 27th August 2008.) With Good NET PROFIT With EPS 11/- for 2008-09. First Quarter Net profit was 2.88 Crores. Second Quarter NetProfit was 2.98 Crores. Equity 11.5 Crores, Company Projected EPS for 2008-09 is 11/- with Net Profit 16Crores. As per This PE only 2. Normally PharmaCompanies PE will be minimum 10. If we take PE 5 It will come 55/-. (PE will take Based on Good Bussiness Group & Pharma Industry).
Daily accumulating Big Big Mumbai BULLS and Operators (Daily above 80% delivery postions check nseindia & bseindia websites); Because of Now stock is available at very very cheep price at 21.35/- . Projected Annual EPS 11/- for 2008-2009, with PE 2 only. Narmally in worst condition also Pharma companies PE will at 5 But Now PE is only 2.Safe Investment at 21.35/-.This share is falling because of Market Down, Company circles are taking this as advantage for grabbing with cheep price. Daily Grabbing with Company Circles. Its very Valuable share at 21.35/- . Risk is very very less at current price.
Total Equity of 11.5 Crores (Its very small Equity in Pharma). Promoters Holding 43.71%; Insurance Companies 6.56%; CorporateBodies 15% Public only 34%
RPG LIFE SCINCES Ltd, R P Goenka Group. RPG Life Sciences Ltd full spectrum, world class, customer focussed, innovative pharmaceutical organisation.
develop, manufacture and market, for national and international markets, a broad range of branded formulations, generics and bulk drugs developed through fermentation and chemical synthesis routes.
Three major activities of RPG Life Sciences Limited are:
· Manufacturing and marketing of bulk drugs (synthetic Active Pharmaceutical Ingredients) & formulations internationally [SBU- I],
· Pharmaceutical formulations & Domestic Marketing [SBU – II] and
· Fermentation & biotechnology [SBU – III].
RPGLS is present in the domestic as well as the international markets. It exports its products primarily to Europe, Latin America, Africa, Australia, CIS Nations & South East Asian countries.
RPGLS employs 750 people. It is a multi-location pharmaceutical manufacturing company with 4 locations. Manufacturing unit at Thane produces Active Pharmaceuticals Ingredients (also called as Bulk Drugs) and is ISO 9001 certified and has Therapeutic Goods Administration (TGA), Australia, and approval for 3 of its major products namely Diphenoxylate Hydrochloride, Haloperidol and Propanthelene Bromide.
The Formulation Plant at Ankleshwar GIDC manufactures pharmaceuticals formulations for Domestic as well as for exports and is ISO 9002 and ISO14001 certified. The site also has MHRA (Medicines and Healthcare products Regulatory Agency, UK) approved plant for catering to its Global Generic business.
The second Plant at Ankleshwar makes API through Fermentation route to cater to the Biotech Business.
RPG LIFE SCINCES Ltd Partnership with
· Dossiers/DMF Europe, Canada
· Artificial Sweetner-UK
· NSAID-Europe
· Formulations – Asia, Canada, Europe
This company has a great future & good company and Equity is very small. Even if we give a conservative P/E of 5, It should be trading at Rs.55/-. So there is a long way to go. Investors with faith in RPG Life Scinces Limited management and having patience will definitely earn a lot.
Possitive Points for this stock for Up moving:
1) Mumbai Bulls and Operators are accumulating at current price. Daily above 80% delivery in NSE and BSE.
2) Company doing very good with EPS 11/- PE only 2; Avialable very cheep at 21.35/-
3) Equity is very small at 11.5 Crores (Pharma Company)
4) Group also very good R P Goenka Group
5) 15% Dividend Paying Company
6) Promoters Holding is good 43.5%
Enter current price at 21.35/- Short term Target 35/- Medium Term Target 55/-
Strong Fundamentals. Risk Free Investment at current price.
Happy Investing…
Bye
BIGBULLS
Subscribe to my newsletter filling the form below. I'll try to make you happy.
Related Posts :
|
|
|
Market Live |
|
|
Loading ...
Hi,
Once again after crash Nifty has started going up. Now we suggest all rises should be used as an opportunity to exit old long positions.
This bull run will continue for few more days. Overall market is in bearish mood as in medium term its just a small rally due to short covering
and result season.
Happy Trading,
ShareGyan
Hi Everyone,
Year 2008 was one of the worst year for all people involved in IT sector and in stock market. In past, financial sector and IT sectors were among the major contributor in the country followed by Auto sector. But now these three sectors are struggling to recover from there losses.
From investors point of view, we are considering it as an opportunity to make fortunes in Indian stock market. Only thing one has to do is to pick right stock at right time.
There are many stocks available in the stock market which can be considered as virgin stock and are ready to blast any time. Now the question arises how to go for stock selection? Which stocks are to be picked and which are to be ignored at these levels.
All investors can simply check Research report and can see why to buy or not.
Regards
Regards
SHARETIPSINFO TEAM